Table: Santen Pharm -2022/23 group forecast(IFRS)

SANTEN PHARMACEUTICAL

27/04/2023 08:00

Apr 27 (Reuters) -
              Santen Pharmaceutical Co Ltd     
              CONSOLIDATED EARNINGS ESTIMATES
  (in billions of yen unless specified)                    
                 Full Year to      Full Year to 
               Mar 31, 2023      Mar 31, 2023   
                  LATEST           PREVIOUS     
                 FORECAST          FORECAST     
  Sales           279.00            272.00      
  Operating      loss 3.10         loss 6.50    
  PreTax         loss 5.80         loss 8.50    
  EPS Basic   loss 38.72 yen    loss 40.01 yen  
 
  NOTE - Santen Pharmaceutical Co Ltd.(Figures are reported based on international accounting rules (IFRS).)    
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4536.T